PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-rearranged NSCLC and Central Nervous System Disease
Clinical Lung Cancer(2024)
关键词
Non-small cell lung cancer,ALK fusion,CNS metastases,ALK TKI
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要